|
ECD expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.323600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.265200E-01 |
| Normal-vs-Stage2 |
7.318800E-03 |
| Normal-vs-Stage3 |
2.836000E-02 |
| Normal-vs-Stage4 |
7.896100E-02 |
| Stage1-vs-Stage2 |
3.016200E-02 |
| Stage1-vs-Stage3 |
1.539960E-01 |
| Stage1-vs-Stage4 |
3.514600E-01 |
| Stage2-vs-Stage3 |
2.735000E-01 |
| Stage2-vs-Stage4 |
1.952630E-01 |
| Stage3-vs-Stage4 |
7.349800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.683500E-02 |
| Normal-vs-AfricanAmerican |
5.997600E-01 |
| Normal-vs-Asian |
1.813200E-01 |
| Caucasian-vs-AfricanAmerican |
6.400500E-02 |
| Caucasian-vs-Asian |
9.972000E-01 |
| AfricanAmerican-vs-Asian |
1.083630E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.234100E-02 |
| Normal-vs-Female |
1.154820E-01 |
| Male-vs-Female |
2.533400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.021000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.080170E-02 |
| Normal-vs-Age(61-80Yrs) |
4.199800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.280800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.029700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.359020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.768000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.216000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.591600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.956800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.425000E-01 |
| Classical-VS-Follicular |
4.97239999996957E-06 |
| Classical-VS-Other |
2.366800E-01 |
| Classical-VS-Normal |
4.844600E-01 |
| Tall-VS-Follicular |
8.965700E-02 |
| Tall-VS-Other |
4.735000E-01 |
| Tall-VS-Normal |
2.076400E-01 |
| Follicular-VS-Other |
7.654000E-01 |
| Follicular-VS-Normal |
8.163700E-04 |
| Other-VS-Normal |
1.874030E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.337200E-03 |
| Normal-vs-N1 |
1.988630E-01 |
| N0-vs-N1 |
2.469400E-01 |
|
|
